📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Clinical trial protocol for TARDOX: a phase I study to investigate the feasibility of targeted release of lyso-thermosensitive liposomal doxorubicin (ThermoDox®) using focused ultrasound in patients with liver tumours. (2017)

First Author: Lyon PC

Attributed to: OxCD3: Oxford Centre for Drug Delivery Devices funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s40349-017-0104-0

PubMed Identifier: 29118984

Publication URI: http://europepmc.org/abstract/MED/29118984

Type: Journal Article/Review

Volume: 5

Parent Publication: Journal of therapeutic ultrasound

ISSN: 2050-5736